Psychosomatic Disorders Terminated Phase 3 Trials for Risperidone (DB00734)

IndicationStatusPhase
DBCOND0063832 (Psychosomatic Disorders)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02374567Pharmacovigilance in Gerontopsychiatric PatientsTreatment